SUBSCRIBE
SUBSCRIBE

Sangamo Therapeutics, Inc.

NEWS
Genetown
Down Syndrome’s Extra Chromosome Silenced, University of Massachusetts Medical School, Sangamo BioSciences, Inc. Study
July 18, 2013
 · 
5 min read
Drug Development
Double Whammy Gene Therapy Clears HIV From Body, Sangamo BioSciences, Inc. Reveals
September 23, 2011
 · 
1 min read
Drug Development
New AIDS Approach Disrupts Patient’s DNA, Sangamo BioSciences, Inc. Announces
February 3, 2009
 · 
1 min read
Biotech Beach
The Week In Review: Biotech Treks Higher
February 5, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Deals Dominate Biotech News
December 12, 2006
 · 
1 min read
The Day In Review: News On Multiple Sclerosis Drugs
September 28, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Diabetes News Rules
June 13, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Pfizer Inc. Buys Another Biotech
April 7, 2006
 · 
1 min read
Biotech Beach
Sangamo BioSciences, Inc. Reports Success Using ZNPs To Fight Aids
December 19, 2005
 · 
1 min read
Load More
AWARDS
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Sangamo Therapeutics Announces Updated Preliminary Phase 1/2 Data in Fabry Disease Clinical Study Showing Continued Tolerability and Sustained Elevated α-gal A Enzyme Activity in Five Longest Treated Patients
August 30, 2022
 · 
9 min read
Business
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results
August 4, 2022
 · 
14 min read
Business
Sangamo Therapeutics Announces Second Quarter 2022 Conference Call and Webcast
July 28, 2022
 · 
1 min read
Biotech Bay
European Orphan Medicinal Product Designation Granted to Sangamo Therapeutics Investigational CAR-Treg Cell Therapy TX200 for Solid Organ Transplantation
July 21, 2022
 · 
5 min read
Biotech Bay
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences - June 01, 2022
June 1, 2022
 · 
1 min read
Business
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
May 5, 2022
 · 
13 min read
Biotech Bay
Sangamo Therapeutics to Present Data From Its Next-Generation Technologies at 2022 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 2, 2022
 · 
5 min read
Business
Sangamo Therapeutics Announces First Quarter 2022 Conference Call and Webcast
April 28, 2022
 · 
1 min read
Biotech Bay
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences - Apr 21, 2022
April 21, 2022
 · 
1 min read
Drug Development
Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation
March 29, 2022
 · 
6 min read
Load More